Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease
Juan Marín‐Lahoz, Frederic Sampedro, Saül Martínez‐Horta, et al.
Annals of Neurology (2019) Vol. 86, Iss. 5, pp. 762-769
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M.A. de Bie, Carl E Clarke, Alberto J. Espay, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 5, pp. 452-461
Closed Access | Times Cited: 156
The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 155
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
Tamara Pringsheim, Gregory S. Day, Don B. Smith, et al.
Neurology (2021) Vol. 97, Iss. 20, pp. 942-957
Open Access | Times Cited: 53
Genetic prediction of impulse control disorders in Parkinson's disease
Daniel Weintraub, Marijan Posavi, Pierre Fontanillas, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 7, pp. 936-949
Open Access | Times Cited: 28
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 20
Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management
Federico Carbone, Atbin Djamshidian
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 443-457
Open Access | Times Cited: 6
Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease
Roshan Cools, Jorryt Tichelaar, Rick C. Helmich, et al.
Progress in brain research (2022), pp. 309-343
Open Access | Times Cited: 27
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Michele Fusaroli, Stefano Polizzi, Luca Menestrina, et al.
Drug Safety (2024) Vol. 47, Iss. 12, pp. 1275-1292
Open Access | Times Cited: 5
Impulse control disorders in Parkinson’s disease: What’s new?
Ana Marqués, Simon J.G. Lewis
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access
Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease
Emma Whooley, Vincent Koppelmans, Hayley J. MacDonald, et al.
Journal of Neuropsychology (2025)
Open Access
Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations
Diego Santos‐García, Javier Pagonabarraga Mora, Francisco Escamilla‐Sevilla, et al.
Neurología (2025) Vol. 40, Iss. 2, pp. 171-181
Open Access
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics
Luis Agüera‐Ortiz, R. García-Ramos, Francisco J. Grandas Pérez, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 31
Comparative efficacy and acceptability of drug treatments for Parkinson’s disease with depression: A systematic review with network meta-analysis
Xiaole Wang, Sitong Feng, Yating Wang, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175070-175070
Closed Access | Times Cited: 17
Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling
Jorryt Tichelaar, Ceyda Sayalı, Rick C. Helmich, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3676-3689
Open Access | Times Cited: 10
Neural correlates of impulse control behaviors in Parkinson’s disease: Analysis of multimodal imaging data
Hamzah Hamid Baagil, Christian Hohenfeld, Ute Habel, et al.
NeuroImage Clinical (2023) Vol. 37, pp. 103315-103315
Open Access | Times Cited: 9
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease
Silvia Cerri, Fabio Blandini
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 18, pp. 2279-2291
Closed Access | Times Cited: 25
Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis
Lanxiao Cao, Tian Xu, Gaohua Zhao, et al.
Journal of Neurology (2021) Vol. 269, Iss. 3, pp. 1298-1315
Closed Access | Times Cited: 21
Tratamiento farmacológico de los síntomas motores de la enfermedad de Parkinson: actualización y recomendaciones de un experto
Jaime Kulisevsky
Revista de Neurología (2022) Vol. 75, Iss. S04, pp. S1-S1
Open Access | Times Cited: 14
Prognosis of impulse control disorders in Parkinson’s disease: a prospective controlled study
Thomas Wirth, Thibaut Goetsch, Jean‐Christophe Corvol, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2412-2422
Closed Access | Times Cited: 2
Associations between Sleep Disorders and Impulsive-Compulsive Behaviors in Parkinson’s Disease: A Prospective Cohort Study
Meijie Ye, Xiaoying Kang, Ida Karlsson, et al.
Neuroepidemiology (2024), pp. 1-8
Open Access | Times Cited: 2
Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome
Ronald B. Postuma, Daniel Weintraub, Tanya Simuni, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 8, pp. 983-991
Open Access | Times Cited: 2
Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease?
Maria Livia Fantini, Janel Fedler, Bruno Pereira, et al.
Annals of Neurology (2020) Vol. 88, Iss. 4, pp. 759-770
Open Access | Times Cited: 14
Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
Juan Marín‐Lahoz, Saül Martínez‐Horta, Javier Pagonabarraga, et al.
Annals of Neurology (2022) Vol. 92, Iss. 6, pp. 974-984
Open Access | Times Cited: 8
Relationship between sleep disorders and neuropsychiatric symptoms in Parkinson's disease: A narrative review
Anastasiia D. Shkodina, Tymur Iengalychev, К. А. Tarianyk, et al.
Acta Facultatis Medicae Naissensis (2022) Vol. 39, Iss. 3, pp. 259-274
Open Access | Times Cited: 8
Olfactory dysfunction and long-term trajectories of sleep disorders among early Parkinson’s disease: findings from a longitudinal cohort
Meijie Ye, Qianqian Ji, Qi Liu, et al.
Neuroepidemiology (2024), pp. 1-10
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top